Technological advancements are expanding the ways clinicians can effectively treat cancer, with new modalities and drug therapies becoming available. The chief medical officer of Genentech, Levi Garraway, expressed excitement about the possibilities that technology is opening up in the field of oncology. This surge of new medicines, from small molecules to cell therapies, is allowing for more targeted and personalized treatments for various types of cancer. One example highlighted is the drug Enhertu, which recently received a tumor-agnostic approval from the FDA. These advancements are leading to the potential for earlier lines of therapy and treatment for a wider range of cancer types each year.
Source link
At ASCO, pharma leaders speak of advances in ‘smart bomb’ drugs
